Drug Shortage Report for BIO-EZETIMIBE
Report ID | 103954 |
Drug Identification Number | 02425211 |
Brand name | BIO-EZETIMIBE |
Common or Proper name | EZETIMIBE |
Company Name | BIOMED PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | EZETIMIBE |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C10AX |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-01-20 |
Estimated end date | |
Actual end date | 2020-02-06 |
Shortage status | Resolved |
Updated date | 2020-02-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-02-07 | English | Compare |
v4 | 2020-02-06 | French | Compare |
v3 | 2020-02-06 | English | Compare |
v2 | 2020-01-22 | French | Compare |
v1 | 2020-01-22 | English | Compare |
Showing 1 to 5 of 5